Lido Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
4,082
-355
| -8% | -$91.6K | ﹤0.01% | 746 |
|
|
2025
Q1 | $993K | Buy |
4,437
+486
| +12% | +$109K | ﹤0.01% | 731 |
|
|
2024
Q4 | $904K | Buy |
3,951
+503
| +15% | +$115K | ﹤0.01% | 737 |
|
|
2024
Q3 | $842K | Buy |
3,448
+629
| +22% | +$154K | ﹤0.01% | 715 |
|
|
2024
Q2 | $540K | Buy |
2,819
+709
| +34% | +$136K | ﹤0.01% | 814 |
|
|
2024
Q1 | $418K | Buy |
2,110
+361
| +21% | +$71.5K | ﹤0.01% | 869 |
|
|
2023
Q4 | $301K | Buy |
1,749
+123
| +8% | +$21.2K | ﹤0.01% | 928 |
|
|
2023
Q3 | $240K | Buy |
1,626
+145
| +10% | +$21.4K | ﹤0.01% | 905 |
|
|
2023
Q2 | $324K | Sell |
1,481
-18
| -1% | -$3.93K | ﹤0.01% | 801 |
|
|
2023
Q1 | $328K | Buy |
1,499
+434
| +41% | +$95.1K | ﹤0.01% | 766 |
|
|
2022
Q4 | $222K | Sell |
1,065
-76
| -7% | -$15.8K | ﹤0.01% | 783 |
|
|
2022
Q3 | $249K | Buy |
1,141
+62
| +6% | +$13.5K | ﹤0.01% | 729 |
|
|
2022
Q2 | $226K | Buy |
1,079
+4
| +0.4% | +$838 | ﹤0.01% | 729 |
|
|
2022
Q1 | $260K | Buy |
1,075
+62
| +6% | +$15K | ﹤0.01% | 761 |
|
|
2021
Q4 | $263K | Buy |
1,013
+49
| +5% | +$12.7K | ﹤0.01% | 757 |
|
|
2021
Q3 | $254K | Buy |
964
+49
| +5% | +$12.9K | ﹤0.01% | 707 |
|
|
2021
Q2 | $226K | Buy |
+915
| New | +$226K | ﹤0.01% | 716 |
|
|
2020
Q3 | – | Sell |
-1,598
| Closed | -$307K | – | 600 |
|
|
2020
Q2 | $307K | Buy |
+1,598
| New | +$307K | 0.01% | 386 |
|